Evidence map›Paper›PMID 24847329›Full record

ReviewCardiorenal medicine2014

Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations.

Keith C Ferdinand, Fatima Rodriguez, Samar A Nasser, A Enrique Caballero, Gary A Puckrein, Farhad Zangeneh, Michael Mansour, JoAnne Micale Foody, Priscilla E Pemu, Elizabeth O Ofili

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cardiorenal medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Trends in Hospitalization for Diverticulitis and Diverticular Bleeding in the United States From 2000 to 2010.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2016
    Article
  16. Distinct temporal phases of microvascular rarefaction in skeletal muscle of obese Zucker rats.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Keith C FerdinandTulane University School of Medicine, New Orleans, La., USA.
Fatima RodriguezBrigham and Women's Hospital, Joslin Diabetes Center, Harvard Medical School, Boston, Mass., USA.
Samar A NasserDepartment of Clinical Research and Leadership, George Washington University, Washington, D.C., USA.
A Enrique CaballeroLatino Diabetes Initiative, Joslin Diabetes Center, Harvard Medical School, Boston, Mass., USA.
Gary A PuckreinDepartment of National Minority Quality Forum, Washington, D.C., USA.
Farhad ZangenehDepartment of Medicine, School of Medicine and Health Services, George Washington University, Washington, D.C., USA.
Michael MansourDepartment of Medicine, University of Mississippi Medical Center, Jackson, Miss., USA ; Delta Regional Medical Center, Greenville, Miss., USA.
JoAnne Micale FoodyDepartment of Clinical Research and Leadership, George Washington University, Washington, D.C., USA.
Priscilla E PemuDepartment of Medicine, Morehouse School of Medicine, Atlanta, Ga., USA.
Elizabeth O OfiliDepartment of Medicine, Morehouse School of Medicine, Atlanta, Ga., USA.

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Research Desogn and Biostatistics CoreU54MD007588 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MAYBERRY, ROBERT M · 2012 to 2018
$24.8M
Renewal Application for Clinical Research Education and Career Development (CRECDR25MD007589 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI PRISCILLA E PEMU, Alexander Quarshie · 2012 to 2026
$5.4M
NCATS NIH HHS UL1 TR000454NIMHD NIH HHS R25 MD007589NIMHD NIH HHS U54 MD007588
6 · The paper itself

Abstract

Cardiovascular disease (CVD), including heart disease and stroke, is the leading cause of death in the USA, regardless of self-determined race/ethnicity, and largely driven by cardiometabolic risk (CMR) and cardiorenal metabolic syndrome (CRS). The primary drivers of increased CMR include obesity, hypertension, insulin resistance, hyperglycemia, dyslipidemia, chronic kidney disease as well as associated adverse behaviors of physical inactivity, smoking, and unhealthy eating habits. Given the importance of CRS for public health, multiple stakeholders, including the National Minority Quality Forum (the Forum), the American Association of Clinical Endocrinologists (AACE), the American College of Cardiology (ACC), and the Association of Black Cardiologists (ABC), have developed this review to inform clinicians and other health professionals of the unique aspects of CMR in racial/ethnic minorities and of potential means to improve CMR factor control, to reduce CRS and CVD in diverse populations, and to provide more effective, coordinated care. This paper highlights CRS and CMR as sources of significant morbidity and mortality (particularly in racial/ethnic minorities), associated health-care costs, and an evolving index tool for cardiometabolic disease to determine geographical and environmental factors. Finally, this work provides a few examples of interventions potentially successful at reducing disparities in cardiometabolic health.

Indexed as

Cardiometabolic riskCardiorenal metabolic syndromeDisparitiesMetabolic syndromeRacial/ethnic minorities

Identifiers

PMID24847329
PMCPMC4024509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.